AMBREEN AHSAN SHAH LIMITED
Executive Summary
The company shows improving financial strength with increased net assets and positive working capital after its first two years of operation. Liquidity appears sufficient for current obligations, but limited historical data warrants conservative credit exposure with ongoing monitoring. Approval is recommended with prudent limits and review conditions to manage risk effectively.
View Full Analysis Report →- Legal registered address
- 18-20 High Street, Stevenage 18-20 High Street Stevenage England SG1 3EJ Copied!
Latest financial results as of 22 August 2025- Current assets
- £16.99k
- Fixed assets
- £713
- Current creditors
- £8.86k
- Shareholders funds
- £8.84k
View full financial accounts- Current assets
- £16.99k
- Fixed assets
- £713
- Current creditors
- £8.86k
- Shareholders funds
- £8.84k
- Company number
- 14226601 Copied!
Accounts
Latest annual accounts were to 31 July 2024
Next annual accounts are due by 30 April 2026
Company financial year end is on 31 July 2026
Confirmation statement
Latest confirmation statement statement dated 10 July 2024
Next statement due by 24 July 2025
Nature of business (SIC)
78300 - Human resources provision and management of human resources functions
86210 - General medical practice activities
Latest company documents
| Date | Description |
|---|---|
| 29/01/2529 January 2025 | Micro company accounts made up to 2024-07-31 |
| 28/01/2528 January 2025 | Change of details for Dr Ambreen Ahsan Shah as a person with significant control on 2025-01-28 |
| 28/01/2528 January 2025 | Director's details changed for Dr Ambreen Ahsan Shah on 2025-01-28 |
| 28/01/2528 January 2025 | Director's details changed for Dr Syed Ahsan Mahmood Shah on 2025-01-28 |
| 31/07/2431 July 2024 | Annual accounts for year ending 31 Jul 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company